University of Nebraska Children's Hospital and Medical Center
Welcome,         Profile    Billing    Logout  
 4 Trials 
14 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Yetman, Angela
FUEL-2, NCT05918211: Fontan Udenafil Exercise Longitudinal Assessment Trial - 2

Recruiting
3
436
US, RoW
Udenafil, Placebo
Mezzion Pharma Co. Ltd
Single Ventricle Heart Disease
10/25
10/25
Wagner, Jonathan B
FUEL-2, NCT05918211: Fontan Udenafil Exercise Longitudinal Assessment Trial - 2

Recruiting
3
436
US, RoW
Udenafil, Placebo
Mezzion Pharma Co. Ltd
Single Ventricle Heart Disease
10/25
10/25
IMPROVE-FALD, NCT06324396: IMProving DRug Dosing and Outcomes for Single VEntricle Patients With Fontan Associated Liver Disease

Recruiting
1
15
US
Sildenafil 10mg oral tablet (participants <20kg), or 20mg oral tablet (participants ≥20kg), Pravastatin 20 mg oral tablet (ages <13 years), or 40 mg oral tablet (≥14 years)
Children's Mercy Hospital Kansas City, Indiana Clinical and Translational Sciences Institute
Fontan Circulation
12/25
12/25
NCT04903223: Liver Adiposity Effects on Pediatric Statin

Recruiting
1
50
US
Rosuvastatin 10mg
Children's Mercy Hospital Kansas City
Cholesterol; Lipidosis
11/25
11/25
Smith, Cynthia
FUEL-2, NCT05918211: Fontan Udenafil Exercise Longitudinal Assessment Trial - 2

Recruiting
3
436
US, RoW
Udenafil, Placebo
Mezzion Pharma Co. Ltd
Single Ventricle Heart Disease
10/25
10/25
NCT05941013: Ultrasound-detectable Endotracheal Tube: a Feasibility Study

Recruiting
N/A
20
US
Ultrasound detectable cuffed endotracheal tube (USD-ETT)
John R. Charpie
Cardiac Catheterization, Endotracheal Tube
03/26
04/26
NCT05632640: Post Anesthesia Care Unit (PACU) Weighted Blanket Study

Recruiting
N/A
120
US
Standard of Care, Weighted blanket
University of Michigan
Cardiac Catheterization, Electrophysiology Procedure, Pediatric Cardiology
03/25
03/25
CHATT, NCT05835063: A Study to Improve Physician-Youth Communication and Medical Decision Making

Completed
N/A
62
US
We Chatt communication tool, Usual/standard care
University of Michigan, National Heart, Lung, and Blood Institute (NHLBI)
Heart Failure NYHA Class II, Heart Failure NYHA Class III, Heart Failure NYHA Class IV
06/24
06/24
Dallas, Lexie
FUEL-2, NCT05918211: Fontan Udenafil Exercise Longitudinal Assessment Trial - 2

Recruiting
3
436
US, RoW
Udenafil, Placebo
Mezzion Pharma Co. Ltd
Single Ventricle Heart Disease
10/25
10/25
NCT05493709: Efficacy, Safety, and Pharmacokinetics of Leuprolide Mesylate in Subjects with Central Precocious Puberty

Recruiting
3
93
US, RoW
Leuprolide Mesylate, Subcutaneous injection of 42 mg Leuprolide
Foresee Pharmaceuticals Co., Ltd., QPS Holdings LLC, Changchun GeneScience Pharmaceutical Co., Ltd.
Puberty; Precocious, Central
11/25
06/26
MoD, NCT04039464: Mono vs. Dual Therapy for Pediatric Pulmonary Arterial Hypertension

Recruiting
3
100
Canada, US
Mono-Therapy with Sildenafil, Revatio monotherapy, Duo-Therapy with Sildenafil + Bosentan, Dual therapy with Revatio and Tracleer
Johns Hopkins University, National Heart, Lung, and Blood Institute (NHLBI), National Center for Advancing Translational Sciences (NCATS)
Pediatric Pulmonary Hypertension
09/26
09/26
Collins, Michelle
FUEL-2, NCT05918211: Fontan Udenafil Exercise Longitudinal Assessment Trial - 2

Recruiting
3
436
US, RoW
Udenafil, Placebo
Mezzion Pharma Co. Ltd
Single Ventricle Heart Disease
10/25
10/25
Vranicar, Mark
FUEL-2, NCT05918211: Fontan Udenafil Exercise Longitudinal Assessment Trial - 2

Recruiting
3
436
US, RoW
Udenafil, Placebo
Mezzion Pharma Co. Ltd
Single Ventricle Heart Disease
10/25
10/25
Decker, Jamie
FUEL-2, NCT05918211: Fontan Udenafil Exercise Longitudinal Assessment Trial - 2

Recruiting
3
436
US, RoW
Udenafil, Placebo
Mezzion Pharma Co. Ltd
Single Ventricle Heart Disease
10/25
10/25

Download Options